127 related articles for article (PubMed ID: 2394363)
1. [Characteristics of the clinical course of acute drug-induced agranulocytosis (data of the Hematological Department for the 6-year period--1982-1987)].
Gorokhovskaia GN; Omel'ianenko NM; Kozhurin SV; Kriuchkova LS; Fedotenkov SA; Kiriushina LN
Gematol Transfuziol; 1990 Jun; 35(6):19-21. PubMed ID: 2394363
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and hematological analysis of acute granulocytopenia].
Deptała A; Niemierko E; Sablińska K
Pol Tyg Lek; 1989 Apr; 44(14):327-31. PubMed ID: 2622806
[TBL] [Abstract][Full Text] [Related]
3. [Changes of granulocytes during the recovery period of agranulocytosis, and in vitro CFU assay for the determination of causative drugs].
Kuriya S; Dan K; Nomura T; Hamaguchi H; Sakamaki H; Amano M; Kawada K
Rinsho Ketsueki; 1982 May; 23(5):634-42. PubMed ID: 7131795
[No Abstract] [Full Text] [Related]
4. Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis.
Tajiri J; Noguchi S
Thyroid; 2004 Jun; 14(6):459-62. PubMed ID: 15242574
[TBL] [Abstract][Full Text] [Related]
5. Quinidine-induced agranulocytosis of abrupt onset.
Sureda A; Hernández Madrid A; Pérez Vaquero MA; Pérez de Oteyza J; Escribano L; Odriozola J
Acta Haematol; 1990; 84(1):43-4. PubMed ID: 2117328
[TBL] [Abstract][Full Text] [Related]
6. Clozapine-lithium combined treatment and agranulocytosis.
Valevski A; Modai I; Lahav M; Weizman A
Int Clin Psychopharmacol; 1993; 8(1):63-5. PubMed ID: 8473724
[TBL] [Abstract][Full Text] [Related]
7. Use of cytokines in clozapine-induced agranulocytosis.
Chin-Yee I; Bezchlibnyk-Butler K; Wong L
Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
[TBL] [Abstract][Full Text] [Related]
8. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring.
Tajiri J; Noguchi S; Murakami T; Murakami N
Arch Intern Med; 1990 Mar; 150(3):621-4. PubMed ID: 2310281
[TBL] [Abstract][Full Text] [Related]
9. [Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis].
Tajiri J; Noguchi S; Morita M; Tamaru M; Murakami N
Nihon Naibunpi Gakkai Zasshi; 1993 Oct; 69(9):1013-6. PubMed ID: 7505241
[TBL] [Abstract][Full Text] [Related]
10. [Problem of side effects of leponex on blood (multicenter inter- national study)].
Panteleeva GP; Gamkrelidze ShA; Dikaia VI; Magalif AA; Okuneva TP; Perevozniuk AG; Shtemberg K; Filip V; German E; Zapletanek M
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(10):70-3. PubMed ID: 1665659
[TBL] [Abstract][Full Text] [Related]
11. [Transient agranulocytosis in the course of treatment with sulfamethoxazole-trimethoprim].
Destaing F; Villand J; Carli H; Carli PM; Martin F; Klepping C
Ann Med Interne (Paris); 1972 Feb; 123(2):129-34. PubMed ID: 5055069
[No Abstract] [Full Text] [Related]
12. Methimazole-induced agranulocytosis preceded by transient granulocytopenia. A case report.
Schut NH; Wiersinga WM; Van Oers MH
Neth J Med; 1993 Aug; 43(1-2):71-3. PubMed ID: 8232698
[TBL] [Abstract][Full Text] [Related]
13. D-penicillamine-induced agranulocytosis: hematological remission upon treatment with recombinant GM-CSF.
Petrides PE; Gerhartz HH
Z Rheumatol; 1991; 50(5):328-9. PubMed ID: 1776370
[No Abstract] [Full Text] [Related]
14. Neutropenia associated with oral acyclovir and multiple antibacterial agents in a patient with acquired immunodeficiency syndrome.
McPherson ML; Plaisance KI
Clin Pharm; 1988 May; 7(5):398-401. PubMed ID: 3383546
[No Abstract] [Full Text] [Related]
15. Polymorphisms of NAT2 in relation to sulphasalazine-induced agranulocytosis.
Wadelius M; Stjernberg E; Wiholm BE; Rane A
Pharmacogenetics; 2000 Feb; 10(1):35-41. PubMed ID: 10739170
[TBL] [Abstract][Full Text] [Related]
16. Population-based drug-induced agranulocytosis.
Ibáñez L; Vidal X; Ballarín E; Laporte JR
Arch Intern Med; 2005 Apr; 165(8):869-74. PubMed ID: 15851637
[TBL] [Abstract][Full Text] [Related]
17. [Agranulocytosis as a complication of acute infectious mononucleosis].
Brkić S; Aleksić-Dordević M; Belić A; Jovanović J; Bogdanović M
Med Pregl; 1998; 51(7-8):355-8. PubMed ID: 9769672
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment.
Kobayashi S; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Ohye H; Suzuki M; Yoshihara A; Iwaku K; Sugino K; Ito K
Thyroid; 2014 May; 24(5):796-801. PubMed ID: 24341564
[TBL] [Abstract][Full Text] [Related]
19. [Immunologic disorders related to granulocytes. II. Agranulocytosis].
Majczak-Błaszczyk W
Pediatr Pol; 1982; 57(10):865-70. PubMed ID: 7182776
[No Abstract] [Full Text] [Related]
20. Spironolactone-induced agranulocytosis.
Jivraj KT; Noseworthy TW; Friesen EG; Shustack AS; Konopad EM; Johnston RG
Drug Intell Clin Pharm; 1987 Dec; 21(12):974-5. PubMed ID: 3428161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
